Volume: 2, Issue: 3
ABSTRACT
Throughout its existence, the pharmaceutical business has a substantial impact on the environment. Numerous activities, including medication discovery, production, distribution, and disposal, add to environmental issues. Pollution is caused by the emission of various chemicals and by-products from manufacturing operations, such as organic pollutants and solvents. Furthermore, the manufacturing and consumption of pharmaceuticals may leave behind residues that contaminate waterways, endangering both human health and ecosystems. Greenhouse gas emissions are a result of the industry's energy-intensive processes, which include the synthesis of active chemicals. If waste generation is not adequately handled, it can result in soil pollution from everything from packaging to outdated drugs. Furthermore, some plant-based components may lead to habitat damage and deforestation. The transportation sector's carbon footprint is further complicated by both local and international transportation. While green chemistry and other practises are serving to advance sustainability, regarding ethical sourcing, persistent efforts are required to effectively control the environmental footprint of the pharmaceutical industry.
